Blog
Forbes Global 2000: The World’s Largest Healthcare Companies In 2022
The second year of the Covid-19 pandemic continued to be a boon to the world’s largest pharmaceutical companies that have developed vaccines and therapeutics to combat the virus. With the spread of new variants, the federal government has recommended booster shots and more widespread availability of anti-Covid drugs, as society grapples with the shift towards an endemic virus that will be around for the long haul. Health insurers saw high costs from Covid patients, but these were partially offset by higher enrollment in Obamacare and Medicare Advantage plans and other patients still deferring non-urgent and elective surgeries.
Read moreHealth Innovation for Pharma Research Webinar
You are invited to @GalenGrowth's upcoming webinar on the 28th of June about Health Innovation and Pharma Research. To sign up for the webinar, click here.
Read moreHow Healthcare Can Employ Robotics To Address Patient Immobility
Immobility in patients has always been an issue at home or at a hospital. It can be a result of a neurodegenerative disease, stroke, or even a bone fracture, making it challenging to move a person from one place to another without hitting a road bump. It will usually take a few people to lift someone off the bed, and if you repeat it several times a day and throughout the years, it will rack up to hundreds of lost clinical hours at any healthcare facility. Perhaps, robotics in healthcare can be a breakthrough technology in this sector.
Read moreThe Cereal Entrepreneur - Running for Heroes
In this episode, The Startups Magazine speaks to Olivia Strong MBE, Founder of Run for Heroes all about how the run 5, donate 5, nominate 5 came about and where they are now the pandemic is over. Read more here.
Read moreAn Employer’s Guide To Digital Healthcare
Nicholas Domnisch is the CEO & Partner of EE Solutions, an NYC-based software development agency empowering innovation in digital health.
Read moreRectal Cancer Disappears After Experimental Use of Immunotherapy
12 patients with rectal cancer treated with dostarlimab - an anti PD1 monoclonal antibody with complete response. A very encouraging study for patients with stage 2/3 rectal cancer. More info here.
Read moreInsomnia is common during menopause & can have a HUGE impact on your ability to function properly
What can you do about it? Check out Kensa Health latest blog post on sleep and #menopause #perimenopause. Click here.
Read moreInside Redesign Health’s Bid To Change The Healthcare Innovation Cycle
Often misunderstood, Redesign Health’s model is a very different way to create, fund and launch healthcare startups, but will it pay off over the long term?
Read moreThousands of UK workers begin world’s biggest trial of four-day week
More than 3,300 workers at 70 UK companies, ranging from a local chippy to large financial firms, start working a four-day week from Monday with no loss of pay in the world’s biggest trial of the new working pattern. Read more…
Read moreBringing The Human Connection Back To Healthcare
“Reigniting the Human Connection” is released with ForbesBooks This release is posted on behalf of ForbesBooks (operated by Advantage Media Group under license). NEW YORK (May 10, 2022) — Reigniting the Human Connection: A Pathway to Diversity, Inclusion, and Health Equity by Dr. Jennifer Mieres, Dr. Elizabeth McCulloch, and Dr. Michael Wright is available now. The book is published with ForbesBooks, the exclusive business book publishing imprint of Forbes, and is available on Amazon today.
Read moreA Vision Of Healthcare 3.0
Healthcare is entering its third evolutionary stage. According to a report by Deloitte, the primary focus during the first stage was on institutions; medical providers were the "source of ultimate reference." The second stage saw a greater focus on doctors, with medical providers seen as having a more advisory role on health matters. Today, the patient is at the heart of everything, able to access information and advice from a range of sources and often determining their own health outcome. Healthcare 3.0, as this current stage is known, is a forward-looking aspiration for a world in which healthcare is transformed by digital solutions: a patient-centric world where healthcare is convenient and seamless.
Read moreApplications for P4SY Precision Medicine Accelerator South Yorkshire 2022 are open!
The P4 Precision programme seeks the world’s leading Precision Medicine startups to support through development, regulation, investment, adoption and scale to UK and international markets to innovate and advance the healthcare landscape. Applications for P4SY Precision Medicine Accelerator South Yorkshire 2022 are…
Read more